4//SEC Filing
Sandler Andrew Seth 4
Accession 0001626199-23-000025
CIK 0001626199other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:32 PM ET
Size
5.8 KB
Accession
0001626199-23-000025
Insider Transaction Report
Form 4
Sandler Andrew Seth
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2023-01-05+50,000→ 50,000 totalExercise: $7.24Exp: 2033-01-04→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0001596060
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:32 PM ET
- Size
- 5.8 KB